Adenomyosis Treatment in Ahmedabad

You have had two failed IVF cycles. Your embryos were good quality. Your protocol looked right. And yet — nothing. Your consultant reviews the results. Nobody mentions the uterus.

This is one of the most common clinical scenarios we see at Wellspring IVF. And in a significant proportion of these cases, the answer has been sitting on the ultrasound report the entire time — quietly described as a “bulky uterus” or “heterogeneous myometrium.” Two words that are frequently documented and almost never explained.

Adenomyosis is defined as the presence of endometrial glands and stroma — the tissue that normally lines the inside of the uterus — within the myometrium (the muscular wall of the uterus). Each month, when oestrogen and progesterone rise in preparation for a potential pregnancy, this misplaced endometrial tissue responds exactly as the normal lining does: it thickens and attempts to shed. But because it is trapped inside the muscle wall, it cannot escape. The result is local inflammation, bleeding within the muscle, fibrosis, and progressive enlargement of the uterus.

This is why the uterus in adenomyosis looks and feels different. On ultrasound, it appears bulky and globular. The walls are asymmetrically thickened. The texture of the myometrium looks heterogeneous — streaky, irregular, with tiny cysts and increased vascularity. It is a uterus in a state of chronic internal inflammation.

The critical distinction from fibroids: adenomyosis is not a separate growth. You cannot remove it the way you remove a fibroid. The adenomyotic process is diffuse throughout the myometrium — in mild cases it may be focal, but in moderate to severe cases the entire uterine wall is involved. This is why medical suppression — not surgery — is the established first-line approach to adenomyosis management before IVF.

Adenomyosis is frequently dismissed as ‘just bad periods.’ The reality is more complex — and the fertility implications far more serious than the symptom picture alone suggests:

The Silent Presentation: Some women with adenomyosis have minimal or no pain. Their only presentation is repeated IVF failure with good-quality embryos, or unexplained recurrent miscarriage. This is the most diagnostically dangerous presentation — because without pain as a trigger, the adenomyosis is never specifically looked for.

Adenomyosis is one of the most underdiagnosed conditions in gynaecology. A standard 2D transvaginal ultrasound, interpreted by a non-specialist, frequently misses focal adenomyosis entirely or reports it simply as a ‘bulky uterus’ — without communicating the clinical significance to the patient or the referring IVF team. Dr. Pranay Shah’s diagnostic approach is layered and systematic:

Step-by-Step Diagnosis at Wellspring IVF

Not all adenomyosis is equal. The severity and extent of disease directly determines the duration of GnRH suppression required before IVF, and informs realistic success rate expectations. Dr. Shah uses a modified grading system based on MRI and TVS findings:

The most important clinical tool in adenomyosis IVF management is GnRH agonist suppression — a medically induced, temporary, reversible low-oestrogen state that ‘quiets’ the uterus before embryo transfer. This is not a new technique — but its systematic, protocol-driven application specifically for adenomyosis patients is what differentiates experienced fertility specialists from generalists.

Read our complete guides: Endometriosis Treatment  |  Uterine Fibroids Treatment.

Dr. Shah’s management of adenomyosis is individualised. The approach depends on symptom severity, fertility intent, age, ovarian reserve, and prior treatment history:

• When surgery is considered: Surgery for adenomyosis is uncommon as a fertility intervention — unlike fibroids, there is no clean plane of dissection. However, in carefully selected cases of focal (localised) adenomyosis with a discrete adenomyoma (adenomyosis tissue forming a pseudo-mass), laparoscopic or open adenomyomectomy can be considered.
• The risk: Surgical excision of adenomyosis carries significant risk of damage to surrounding normal myometrium — potentially impairing uterine integrity and increasing rupture risk in pregnancy. Dr. Shah considers this only after MRI confirms focal disease and medical management has failed.
• Hysterectomy: The only definitive surgical cure for adenomyosis. Appropriate only for women who have completed their families and whose quality of life is severely impaired. Never appropriate for women still pursuing pregnancy.
• Endometrial Ablation: NOT appropriate for women seeking pregnancy. Destroys the endometrial lining — eliminating any possibility of future implantation. Mentioned only to explicitly exclude it from the fertility management conversation.

“When I review a couple’s IVF history and see two or three failed transfers with Grade A blastocysts, the first thing I look at is the uterine environment — not the embryo report. In at least one third of these cases, the ultrasound reports from previous cycles use the words ‘bulky uterus’ or ‘heterogeneous myometrium’ — but nobody ever told the couple what that meant, or changed the protocol because of it. Adenomyosis was the answer all along. Two months of suppression, a frozen transfer, and the cycle works. The embryos were never the problem.”

— Dr. Pranay Shah, MS (ObGy), Director & Chief Fertility Consultant, Wellspring IVF & Women’s Hospital, Ahmedabad